Table 2 DenTiUS Deep Plaque clinical indices were obtained in test groups A and B in phase 1 (after using the cymenol and placebo mouthwashes, respectively) and phase 2 (after using the cymenol mouthwash in both groups)
DenTiUS Deep Plaque clinical indices | Test group A (Mean % ± S.D.) | Test group B (Mean % ± S.D.) | p-value |
|---|---|---|---|
Phase 1_Day 0 | |||
Visible plaque area (absolute) | 5.57 ± 3.57 | 5.68 ± 3.53 | 0.906 |
Phase 1_Day 4 | |||
Visible plaque area (absolute) | 35.31 ± 14.93 | 46.57 ± 18.92 | 0.023 |
Visible plaque area (relative) | 29.80 ± 13.97 | 40.53 ± 18.48 | 0.024 |
Total plaque area | 57.49 ± 13.26 | 62.75 ± 16.85 | 0.225 |
Visible plaque area growth (absolute) | 0.36 ± 0.15 | 0.49 ± 0.20 | 0.016 |
Visible plaque area growth (relative) | 0.31 ± 0.14 | 0.43 ± 0.19 | 0.017 |
Total plaque area growth | 0.60 ± 0.13 | 0.66 ± 0.17 | 0.150 |
Phase 2_Day 8 | |||
Visible plaque area (absolute) | 44.79 ± 15.77 | 65.12 ± 16.37 | < 0.001 |
Visible plaque area (relative) | 39.27 ± 14.33 | 59.24 ± 16.90 | < 0.001 |
Total plaque area | 65.17 ± 9.73 | 74.52 ± 13.55 | 0.007* |
Visible plaque area growth (absolute) | 0.23 ± 0.08 | 0.34 ± 0.08 | < 0.001 |
Visible plaque area growth (relative) | 0.20 ± 0.07 | 0.31 ± 0.08 | < 0.001 |
Total plaque area growth | 0.34 ± 0.05 | 0.39 ± 0.07 | 0.005* |